Hepatitis A Virus Seropositivity in Young Individuals: Five-Year Retrospective Evaluation

Özmen, Pelin; Akman, Nazife; Akıdağı, Zeynep; Gökahmetoğlu, Selma

doi:10.54453/tmcd.2024.67689

Turk Mikrobiyol Cemiy Derg

2024

DOI: 10.54453/tmcd.2024.67689

|View full text |Cite

Hepatitis A Virus Seropositivity in Young Individuals: Five-Year Retrospective Evaluation

Pelin Özmen,

Nazife Akman,

Zeynep Akıdağı

et al.

Abstract: Hepatit A Virüsü (HAV), kişiden kişiye direkt temas veya fekal -oral yolla bulaşabilen akut viral hepatitlerin önemli etkenlerinden biridir. Farklı sosyodemografik tabakalarda HAV seroprevalansı değişkenlik gösterse de, her koşulda sağlık çalışanları risk grubunda yer alır. Bu çalışmada, rutin HAV aşılaması kapsamına girmemiş sağlık stajyerlerinde HAV seropozitifliğinin beş yıllık retrospektif değerlendirmesi amaçlanmıştır. Yöntem: Sağlık stajyerlerinde hepatit A serolojilerinin retrospektif olarak değerlendir… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 19 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Examining the changes in the prevalence of Hepatitis a in Türkiye: systematic review and metaanalysis

Karakaya Suzan,

Bektaş,

Altındiş

et al. 2024

BMC Public Health

View full text Add to dashboard Cite

Background The incidence of Hepatitis A is increasing worldwide. Yearly classification of Hepatitis A Seroprevalence for different times in different regions of Türkiye allows indirect measurement of year-specific incidence rates of HAV infection and can be considered the best way to define Hepatitis A status. This study aimed to examine the change in the incidence of hepatitis A by systematically evaluating the available data on the seroprevalence of anti-HAV antibodies in the Turkish population. Methods Studies published between First January, 2000- 31 December 2023 that meet the inclusion criteria searched between 16.09.2023 and 31.01.2024 in nine databases (MEDLINE, Web of Science, PubMed, ScienceDirect, Scopus, Eric, CINAHL Complate, TR DİZİN, TÜBİTAK Ulakbim). Independently by two reviewers evaluated all titles and abstracts with consensus-based decision making. The Joanna Briggs Institution (JBI) Analytical Cross Sectional Studies and Prevelance Studies list were used in this study. Pooled prevalence was calculated using 95% confidence intervals. Heterogeneity between studies was assessed by Cochrane’s Q and I2. The random effect model was selected by Cochrane’s Q and I2. Funnel plots were used for publication bias. The data were analyzed via Jamovi 1.2.22. Results Data were extracted from 63 studies. Pooled prevalence was calculated using 95% confidence intervals. Funnel plots were used for publication bias. In this meta-analysis, data were obtained from all geographical regions of Türkiye, and the general prevalence of Hepatitis A in the population was found to be 53% [95% CI 0.47, 0.59; I2 = 99.94%]. In subgroup analysis conducted by year, the prevalence of hepatitis A was 45% [95% CI 0.22, 0.67; I2 = 99.8%] between 2002 and 2006, 52% [95% CI 0.39, 0.65; I2 = 99.54%] between 2007 and 2011, 60% [95% CI 0.49, 0.70; I2 = 99.9%] between 2012 and 2016, and 51% [95% CI 0.41, 0.61; I2 = 99.97%] as of 2017. Additionally, a systematic review revealed that vaccination, socioeconomic status, and sex may also affect HAV seroprevalence. Conclusions HAV seroprevalence in Türkiye; It was observed that it increased between 2002 and 2016 and decreased until today as of 2017. This systematic review provide a comprehensive overview of HAV virus epidemiology and identify key knowledge gaps, contributing crucial information for influencing factors. Trial registration PROSPERO ID = CRD42023464384.

show abstract

Examining the changes in the prevalence of Hepatitis a in Türkiye: systematic review and metaanalysis

Karakaya Suzan,

Bektaş,

Altındiş

et al. 2024

BMC Public Health

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Hepatitis A Virus Seropositivity in Young Individuals: Five-Year Retrospective Evaluation

Cited by 1 publication

References 19 publications

Examining the changes in the prevalence of Hepatitis a in Türkiye: systematic review and metaanalysis

Examining the changes in the prevalence of Hepatitis a in Türkiye: systematic review and metaanalysis

Contact Info

Product

Resources

About